The Central Authority, Central Drugs Standard Control Organisation (CDSCO) came out with Frequently Asked Questions (FAQs) on the Import and Registration of Drugs in India. Let’s take a look at the FAQs: How is drug import regulated in India? Chapter III of Drugs and Cosmetic Act, 1940, and Part […]
The Central Authority, Central Drugs Standard Control Organisation (CDSCO) came out with Frequently Asked Questions (FAQs) on the Import and Registration of Drugs in India. Let’s take a look at the FAQs:
Chapter III of Drugs and Cosmetic Act, 1940, and Part IV of Drug and Cosmetic Rules provide regulations related to the import of drugs in India.
Import and Registration Division, Central Drugs Standard Control organisation(CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, FDA Bhawan, ITO, Kotla Road, New Delhi-110002 looks after the registration/import of drugs in India.
Veterinary Cell, Central Drugs Standard Control organisation (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, FDA Bhawan, ITO, Kotla Road, New Delhi-110002 looks after the registration/import of drugs in India.
Registration Certificate is a certificate issued under Rule 27A of Drugs and Cosmetics Rules, 1945 by the Licensing Authority in Form 41 for registration of premises and the drugs manufactured by the manufacturer meant for import into and use in India.
Import License is either a license in Form 10 to import of drugs excluding those specified in Schedule X, or a license in Form 10-A to import of drugs specified in Schedule X.
As per regulations, a Manufacturer means a manufacturer of drugs which is either a company or a unit or a body or a corporate or any other establishments in the country (other than India) and have drug manufacturing facilities duly approved by the National Regulatory Authority of the concerned country. They have their free sale approval of the drugs approved by NRA in that country and any other major countries.
Import of Drugs for commercial use in India require Registration Certificate in Form 41 and Import License in Form 10 as per the Drugs and Cosmetics Act, 1940.
Application for Registration Certificate to the Licensing Authority is made in Form 40. According to the rules, this is done by either a manufacturer having a valid wholesale license for sale or distribution of drugs or by the authorised agent in India having valid wholesale license. It needs to be submitted along with fees specified in sub-rule (3) of rule 24 A of the Drugs and Cosmetics Rules 1945 along with the information and undertakings specified in Schedule D- I and D-II duly signed by or behalf of the manufacturer. The applicant submits an application as per the checklist available at https:cdscoonline.gov.in through SUGAM Online Portal.
There is no requirement for inspection before the grant of the registration certificate. In case an inspection is required, then the amount of fees is USD 25,000.
Application for import license is made in Form 8 to the Licensing Authority for drugs excluding those mentioned in Schedule X and in Form 8A for drugs specified in Schedule X. According to the rules, this is done by either by the manufacturer having a valid wholesale license for sale or distribution of drugs or by the authorised agent in India having a valid wholesale license. It needs to be submitted along with license fees of one thousand rupees for each additional drug and an undertaking in Form 9 duly signed by or on behalf of the manufacturer. The applicant submits an application as per the checklist available at https:cdscoonline.gov.in through SUGAM Online Portal.
No. A single application is required, and a single registration certificate/license is issued for import of more than one drug or class of drugs manufactured by the same manufacturer. This is applied if the drugs or classes of drugs are manufactured at one factory or more than one factory working jointly as a single manufacturing unit. The second clause is a separate license or registration in respect of the drugs manufactured by each factory that is required if a single manufacturer has two or more factories situated in different locations manufacturing the same or different drugs.
An Importer needs to apply for endorsement in the already present Registration Certificate with all important documents required for the same. This will be on the condition that the additional drug is manufactured at the same manufacturing site mentioned in the Registration Certificate. Payment of USD 5000 is required for each additional drug. The requirements for endorsement of new additional drugs to the valid Registration Certificate remain the same to the fresh Registration Certificate except for Site Registration fees of USD 10000 and Plant Master File.
Yes. If a product is manufactured at different sites, separate payment of fees with each site related to different activities like manufacturing, primary packaging, batch release, labeling, etc. has to be made. But if the activities are performed in one site then payment of a single fee is required.
The requirements of the re-registration of drugs are the same as fresh registration of the drug.
Sl No. | Legal Form | Fees |
1. | Form 40 | Registration fees of USD 10000(or its equivalent in Indian rupees) for premises meant for the manufacturing of drugs used for import and use in India.
Registration fees of single drug USD 5000(or its equivalent in Indian rupees) for import and use in India and an additional fee at the rate of USD 5000 for each additional drug. |
2. | Form 8 | INR 10000 for a single drug and an additional fee of INR 1000 for each additional drug. |
Note: if the primary packaging site, testing site, batch release site are different from the main manufacturing site, payment of an additional fee of USD 10,000 is required to be done.
The payment should be through Non-Tax receipt portal i.e. www.bharatkosh.gov.in with the below details:
Grant | Head of Account | Description of Non-Tax Receipt | Name of DDO |
900 | 0210-04-1040000-00-1 | Fees and Fines
(Clinical Trials, Import and Registration, New Drug) |
CDSCO(HQ),New Delhi |
The Licensing Authority will grant Registration Certificate in Form 41 within nine months from the date of receipt of an application if all the information and details provided are complete and in order as per provisions of Schedule D- I and D-II.
A Registration Certificate is valid for a period of three years from the date of issue if it is not suspended for any reason. A fresh Registration Certificate is made nine months prior to the expiry of the present one and is continued until new orders are passed for the Registration Certificate.
An Import License is valid till the validity of the Registration Certificate unless it is suspended. A fresh license is made three months prior to the expiry of the present one and is continued until new orders are passed for the Registration Certificate.
Yes.
No. Single license can be issued for import of more than one drug or class of drugs manufactured by the same manufacturer to the importer. Then, Importer can import drugs from any notified ports as per the provisions of the Drugs and Cosmetics Act and Rules.
Yes.
The time period for grant of an Import license in Form 10 is forty five days from the date of receipt of an application if all the documents and information provided are proper and in order.
Yes. The applicant needs to get Post Approval changes before filling for re-registration so that the post approval changes are documented in renewal RC.
Yes. The applicant needs to submit the fresh application along with fees.
The company needs to get RC before applying for an Import License. After the site gets registered, one can apply for an Import license.
The applicant can file for both New Drug Approval and Registration Certificate in case of a new drug. RC will be issued after New Drug Permission.
Yes.
A duly notarized copy of Certificate of Pharmaceutical Products (COPP) is required to be submitted to the Drug authority in India. The certificate should clearly mention that the drug substance is marketed in the exporting country from any other country.
Preferably, one should submit a GMP certificate. However, written document of the active ingredients exported to the European Union given by National Regulatory Authority of the country of origin or a duly notarized copy of the certificate equivalent to the GMP certificate as per WHO GMP guidelines issued by the United States of America or Japan or Australia or Canada or European Union for marketing of drug is essential.
Yes, apostilled POA is accepted.
In situations of emergencies, the Licensing Authority can issue Import license in Form 10 or 10A with the approval of the Central Government as per Sub-rule (2) of rule 24. As the case may be without the issuance of Registration Certificate under rule 27(A) and the reasons to be documented in writing.
According to the Drug and Cosmetics Rules, Registration Certificate/Import license is not required for inactive bulk substance used for the formulation of the drug, with or without pharmacopoeia conformity.
Yes.
Yes. Indian Agent need to inform the licensing authority if there is any change in post approval change applications under SUGAM and get Post Approval Change.
Form 9 is an undertaking to accompany an application for an import license given by Manufacturer/Indian Agent.
No drug should be imported unless it is packed and labelled in conformity with Parts IX and X of Drugs and Cosmetics Rules, 1945 as per Rule 32 of Drugs and Cosmetics Rules.
The Name and Address of Legal Manufacturer or Actual Manufacturer and Importer as defined in Form 10.
Registration Certificate and Import License are not required for the drug transit through India to foreign countries that are not sold or distributed in India.
Imported drugs need to comply with standards under the second schedule of the Drugs and Cosmetics Act, 1940.
Standards like the identity, purity and specified strength of the drug designated in each edition of the official Pharmacopoeia of any other country.
In the situations where identity, purity and strength are not specified in such official Pharmacopoeia but are specified in the edition immediately preceding it then it can be taken as reference.
Yes. The letters I.P. and recognized abbreviations of Pharmacopoeia and the official comendis of drug standards under the Rules need to be mentioned on the label of the drug. This will indicate that the drug is following standards of the Indian Pharmacopeia or any such Pharmacopeia or official compendium of drug standards as per Rules.
The different categories of post approval changes are available under https://cdscoonline.gov.in/CDSCO/Industry.
It is better to get an approval of post-approval amendment before applying for RC renewal/ endorsement, otherwise the post-approval will not be visible in the renewed RC/endorsement.
According to Schedule D of the Drugs and Cosmetics Act, 1945:
Due permission needs to be taken from the Licensing Authority according to the clause(b) of Rule 21 for import of a substance for non-medicinal use without registration and import license.
An Applicant can approach zonal offices of CDSCO for getting dual-use NOC.
No there is no requirement of RC in this case as Rule 43 of Drugs and Cosmetics Rules 1945 has exempted them from provisions of the Chapter III of the Act subject to the conditions specified in Schedule D.
There is no requirement for Registration Certificate/Import License as per the Drug and Cosmetics Rules, 1945 for products like 6-APA, an intermediate of manufacturing for amoxicillin trihydrate.
Import of drugs free of cost for charitable hospitals stating that small amount of drugs received in donation by charitable hospital for the purpose of the treatment of the patients in the said hospital may be imported provided the drugs are given or administered free of cost as per Rule 36A of the Drugs and Cosmetics Act,1945.
Drugs shall not be prohibited for import and permitted to be marketed in the country with a residual shelf life of one or more years.
No.
According to Rule-31 of Drugs and Cosmetics Rules, 1945, No drug shall be imported if it does not comply with the standards of strength, purity and quality. The Licensing Authority should not allow the import of any drug having shelf life less than 60% from the date of import. Sometimes, import is allowed having drug less than 60% before the date of expiry declared in the container in exceptional cases if written document is submitted to the Licensing Authority.
According to the Schedule D of Drugs and Cosmetics Act, 1945, import of drugs for manufacture and export by units located in “Special Economic Zones” as notified by the Government of India are exempted from the provisions of Chapter III of the Act and Rules, it should be covered by import license, import registration and import through notified port of the country. The conditions here are the drugs cannot be diverted for sale in the country.
As per G.SR 1193(E) dated 12/12/2018, revised fees in post approval amendment/changes in RC is as:
Sl No. | Type of amendment | Fees |
1. | Change in foreign manufacturer address in RC(no location change) | USD 1800 |
2. | Change of Shelf-life in RC(Extension) | USD 1800 |
3. | Change of Shelf-life in RC(Reduction) | USD 1800 |
4. | Change in address of registered manufacturer in RC(No location change) | USD 1800 |
5. | Change in the manufacturing process or in packing/labeling/testing/testing/documentation of any drug regarding RC(Minor/Major) | No fee is required for a minor change. But the fee of USD 5000 per product is required for major change/modification in manufacturing process or in packing/labelling/testing/documentation as the case may be discretion of the Licensing Authority. |
6. | Change of the name of the manufacturer in RC without constitution change | USD 1800 |
7. | Change of Pharmacopoeial specification in RC | USD 1800 |
8. | Change of Pharmacopoeial specification of drug ingredients in FF in RC | USD 1800 |
9. | Deletion of the site involved in the manufacturing of drugs | USD 1800 |
Note:
(a)Foreign manufacturer means the manufacturing site which is to be registered in the Registration Certificate.
(b)Registered manufacturer means the address of the firm used for communication purposes like the corporate office address or it can be same as that of the foreign manufacturer.
According to condition no.6 of RC in Form 41 under the rules of the Drug and Cosmetics Rules “the manufacturer or his authorised agent in India shall inform the Licensing Authority immediately in written document in the case of any change in constitution of the firm and address of the registered office/factory premises operating under this RC. In this circumstance, RC will be valid for maximum period of three months from the date of the change. In the meanwhile, a fresh RC is made with the change in constitution or change in address of the registered office or factory premises”.
According to the rules of the Drug and Cosmetics Act, 1940 Companies need to get fresh RC in the following situations:
The Manufacturer or Indian Agent needs to immediately inform the Licensing Authority in writing in the event of any change in the constitution of the firm or change in address of the registered office under which RC is taken. If any change is there then current RC is deemed for three months from the date of change. Otherwise, a fresh RC can be made during his time.
As per GSR 1193, Cases of Registration Certificate where payment of fees USD 1800 are required
Below mentioned cases are considered minor change and fees are not required:
Sl No. | Change | Example |
1. | Change/modification in manufacturing process | i) The manufacturer was manufacturing the dosage of the tablet form with wet granulation method. Presently, the process of manufacturing is modified to direct compression method.
ii) Modification in packaging/packing system like change in packaging from Aluminium foil to Alu-Alu, etc. iii) Change in liquid form of injection to lyophilized form, etc. |
2. | Change/modification in testing | i) Initially testing is conducted by the HPLC method. Later on changed to Gas Chromatography/Microbiological method, etc. |
3. | Change/modification in documentation | i) Change in indication of the drug or addition of indication to the existing approved indication. |
Note: All the changes need to be approved in the country of origin and if the drug is new Form 45 is required.
ICEGATE stands for Indian Customs Electronic Commerce/Electronic Data Interchange (EC/EDI) Gateway. It is a portal that provides e-filling services to the trade and cargo carriers and clients of Customs department (collectively called Trading Partner).
e-SANCHIT is a e-storage and Computerized Handling of Indirect Tax Documents for paperless processing, uploading of related documents that will facilitate trading across borders.
ICEGATE registered users can use e-SANCHIT by e-sanchit link.
IRN is Image Reference Number which is unique to each document. DRN is Document Reference Number which is unique to a batch of uploaded documents. A group of IRN is entered to the Bill of Entry and not DRN.
Applicant needs to apply for a fresh Registration Certificate if validity expires as per the check list given in https://cdscoonline.gov.in/CDSCO/Industry.
Import of radiopharmaceuticals requires submission of No Objection Certificate (NOC) by Atomic Energy Regulatory Board (AERB).
Timeline is started from the date of submission of application at CDSCO. It does not include the time period taken by the applicant to reply to queries and clarifications.
Time period starts from the date of submission of application at CDSCO. It does not include the time required by the applicant to reply to the queries.
You can send your feedback and suggestions to CDSCO at import.regist@cdsco.nic.in within 7 days from the release of the draft notification.
Saurangi is a food regulatory expert with 8 years of experience. She shares her knowledge and insights on regulatory updates, food trends, best practices, and news. Follow her for expert insights and practical advice on all things for food regulatory
CliniExperts Services Pvt. Ltd.
Navigating Software as a Medical Device regulation involves addressing varying global standards, including risk-based classifications...
The future of Software as a Medical Device will see breakthroughs in Artificial Intelligence-based diagnostics, personalised treatments, and remote monitoring...
Software as a Medical Device refers to software applications designed for medical purposes, such as diagnosis, treatment, or monitoring, without being part of a physical device...
Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.